Related Experiment Video
Updated: Aug 13, 2026
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Forskolin: a potential antimetastatic agent
Abstract:
Forskolin, a diterpene from the roots of an Indian plant, Coleus forskohlii, is a potent platelet aggregation inhibitor and has been examined for its effects on (a) tumor-induced human platelet aggregation and (b) pulmonary tumor colonization in mice. These studies employed a subline of B16 murine melanoma, B16-F10 (highly metastatic to lungs). Forskolin (2 microM) strongly inhibits the melanoma cell-induced human platelet aggregation. A single dose of forskolin (82 micrograms/mouse) administered intraperitoneally 30 or 60 min prior to tail vein injection of cultured B16-F10 cells (2 or 3 X 10(5) cells/mouse) reduced tumor colonization in the lungs by more than 70%. Similar results were obtained in three separate experiments. These findings raise the possibility that forskolin could prove of value in the clinic for the prevention of cancer metastasis.
Insights
Forskolin, a natural compound, effectively inhibits cancer cell-induced platelet aggregation. This discovery suggests potential clinical value for forskolin in preventing cancer metastasis.
Area of Science:
- Pharmacology
- Oncology
- Biochemistry
Background:
- Forskolin is a diterpene derived from Coleus forskohlii.
- It is known to be a potent inhibitor of platelet aggregation.
- Cancer metastasis involves complex interactions, including platelet activation.
Purpose of the Study:
- To investigate the effects of forskolin on tumor-induced platelet aggregation.
- To evaluate forskolin's efficacy in preventing pulmonary tumor colonization in a murine model.
Main Methods:
- Utilized B16-F10 murine melanoma cells, known for high lung metastatic potential.
- Assessed inhibition of melanoma cell-induced human platelet aggregation by forskolin (2 microM).
- Administered forskolin (82 micrograms/mouse) prior to B16-F10 cell injection in mice to measure lung tumor colonization reduction.
Main Results:
- Forskolin significantly inhibited melanoma cell-induced human platelet aggregation.
- A single dose of forskolin reduced lung tumor colonization by over 70% in mice.
- Consistent results were observed across three independent experiments.
Conclusions:
- Forskolin demonstrates potent anti-metastatic properties in preclinical models.
- Its ability to inhibit platelet aggregation may contribute to its anti-metastatic effects.
- Forskolin holds potential for clinical application in cancer metastasis prevention.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
01:10Drugs that Destabilize Microtubules